Cue Biopharma, Inc. (CUE) CEO Dan Passeri Hosts Investor Business Update Call (Transcript) [Seeking Alpha]
Cue Biopharma, Inc. (CUE)
US:NASDAQ Investor Relations:
cuebiopharma.gcs-web.com/news-releases
Company Research
Source: Seeking Alpha
Cue Biopharma, Inc. (NASDAQ: CUE ) Investor Business Update Call August 23, 2018 8:30 AM ET Executives John Woolford - Westwicke Partners Dan Passeri - President and CEO Anish Suri - Chief Scientific Officer Bethany Mancilla - Chief Business Officer Kerri-Ann Millar - VP of Finance and Principal Accounting and Finance Officer Analysts Ted Tenthoff - Piper Jaffray Bert Hazlett - BTIG Gil Blum - Needham & Company George Zavoico - B. Riley FBR Yale Jen - Laidlaw & Company Operator Good morning, and welcome to the Cue Biopharma's Investor and Analyst Update Conference Call. All lines have been placed on mute to prevent any background noise. Following the speaker's remarks, there will be a question-and-answer session. I will now turn the call over to the company. John Woolford Good morning. This is John Woolford from Westwicke Partners. Thank you for joining us on today's investor and analyst update call. Joining me on the call today are Cu
Show less
Read more
Impact Snapshot
Event Time:
CUE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CUE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CUE alerts
High impacting Cue Biopharma, Inc. news events
Weekly update
A roundup of the hottest topics
CUE
News
- Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting [Yahoo! Finance]Yahoo! Finance
- Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingGlobeNewswire
- Here's Why Cue Biopharma (CUE) Is a Great 'Buy the Bottom' Stock Now [Yahoo! Finance]Yahoo! Finance
- Cue Biopharma, Inc. (NASDAQ: CUE) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $8.00 price target on the stock.MarketBeat
- Cue Biopharma, Inc. (NASDAQ: CUE) had its "outperform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $10.00 price target on the stock.MarketBeat
CUE
Earnings
- 8/8/23 - Beat
CUE
Sec Filings
- 3/28/24 - Form 10-K
- 3/28/24 - Form S-8
- 3/11/24 - Form SC
- CUE's page on the SEC website